Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
Emerging Infectious Diseases
|
February 25, 2020
Mycobacterium tuberculosis Complex Lineage 3 as Causative Agent of Pulmonary Tuberculosis, Eastern Sudan<sup>1</sup>
Yassir A Shuaib, Eltahir A G Khalil, Lothar H Wieler, et al.
Nature Communications
|
August 30, 2022
Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian clade toward extensively drug resistant tuberculosis
Matthias Merker, Jean-Philippe Rasigade, Maxime Barbier, et al.
Lab on a Chip
|
November 24, 2023
Two-stage tuberculosis diagnostics: combining centrifugal microfluidics to detect TB infection and Inh and Rif resistance at the point of care with subsequent antibiotic resistance profiling by targeted NGS
Judith Schlanderer, Harald Hoffmann, Jan Lüddecke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2021
Design of Multidrug-Resistant Tuberculosis Treatment Regimens Based on DNA Sequencing
Hans-Peter Grobbel, Matthias Merker, Niklas Köhler, et al.
Jac-Antimicrobial Resistance
|
April 25, 2022
Whole genome sequencing-based drug resistance predictions of multidrug-resistant <i>Mycobacterium tuberculosis</i> isolates from Tanzania
Peter M Mbelele, Christian Utpatel, Elingarami Sauli, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
May 27, 2021
Perspectives for systems biology in the management of tuberculosis
Irina Kontsevaya, Christoph Lange, Patricia Comella-Del-Barrio, et al.
Frontiers in Immunology
|
October 29, 2020
Perspective for Precision Medicine for Tuberculosis
Christoph Lange, Rob Aarnoutse, Dumitru Chesov, et al.
Genome Medicine
|
November 26, 2020
MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era
Patrick Beckert, Elisabeth Sanchez-Padilla, Matthias Merker, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 2017
Some Synonymous and Nonsynonymous <i>gyrA</i> Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDR<i>sl</i> Assays
Adebisi Ajileye, Nataly Alvarez, Matthias Merker, et al.
The Journal of Infection
|
February 4, 2023
Pretomanid-resistant tuberculosis
Niklas Koehler, Sönke Andres, Matthias Merker, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
Emerging Infectious Diseases
|
February 25, 2020
Mycobacterium tuberculosis Complex Lineage 3 as Causative Agent of Pulmonary Tuberculosis, Eastern Sudan<sup>1</sup>
Yassir A Shuaib, Eltahir A G Khalil, Lothar H Wieler, et al.
Nature Communications
|
August 30, 2022
Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian clade toward extensively drug resistant tuberculosis
Matthias Merker, Jean-Philippe Rasigade, Maxime Barbier, et al.
Lab on a Chip
|
November 24, 2023
Two-stage tuberculosis diagnostics: combining centrifugal microfluidics to detect TB infection and Inh and Rif resistance at the point of care with subsequent antibiotic resistance profiling by targeted NGS
Judith Schlanderer, Harald Hoffmann, Jan Lüddecke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2021
Design of Multidrug-Resistant Tuberculosis Treatment Regimens Based on DNA Sequencing
Hans-Peter Grobbel, Matthias Merker, Niklas Köhler, et al.
Jac-Antimicrobial Resistance
|
April 25, 2022
Whole genome sequencing-based drug resistance predictions of multidrug-resistant <i>Mycobacterium tuberculosis</i> isolates from Tanzania
Peter M Mbelele, Christian Utpatel, Elingarami Sauli, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
May 27, 2021
Perspectives for systems biology in the management of tuberculosis
Irina Kontsevaya, Christoph Lange, Patricia Comella-Del-Barrio, et al.
Frontiers in Immunology
|
October 29, 2020
Perspective for Precision Medicine for Tuberculosis
Christoph Lange, Rob Aarnoutse, Dumitru Chesov, et al.
Genome Medicine
|
November 26, 2020
MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era
Patrick Beckert, Elisabeth Sanchez-Padilla, Matthias Merker, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 2017
Some Synonymous and Nonsynonymous <i>gyrA</i> Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDR<i>sl</i> Assays
Adebisi Ajileye, Nataly Alvarez, Matthias Merker, et al.
The Journal of Infection
|
February 4, 2023
Pretomanid-resistant tuberculosis
Niklas Koehler, Sönke Andres, Matthias Merker, et al.
Page
of 9